Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
27.95
-0.25 (-0.89%)
Nov 13, 2026, 3:00 PM CST

SHA:603351 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
156.95150.97146.42112.295.03101.37
Depreciation & Amortization
132.11132.11116.0771.7471.7642.81
Other Amortization
0.860.860.091.031.11.13
Loss (Gain) From Sale of Assets
-0.02-0.02--00.05
Asset Writedown & Restructuring Costs
0.420.420.170.180.11.91
Loss (Gain) From Sale of Investments
-3.44-3.44-12-1.440.11-2.25
Provision & Write-off of Bad Debts
0.360.360.340.29-4.482.35
Other Operating Activities
46.3515.5620.2814.2612.216.17
Change in Accounts Receivable
-414.81-414.81-13.57-31.4134.17-105.72
Change in Inventory
-10.12-10.12-40.46-9.38-22.77-29.18
Change in Accounts Payable
365.19365.19-3.98-43.96-106.45-42.06
Change in Other Net Operating Assets
-2.43-2.433.3610.4628.0615.44
Operating Cash Flow
275.01238.24221.79120.24108.99-11.54
Operating Cash Flow Growth
34.57%7.42%84.45%10.33%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-67.09-52.18-51.46-73.07-233.9-235.62
Sale of Property, Plant & Equipment
0.220.22----
Investment in Securities
9.85-22.12-18.535.23-4.73172.72
Other Investing Activities
-0.260.02-0.5-0.95-5.07
Investing Cash Flow
-88.81-74.06-70.48-67.84-237.68-67.97

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-551381.02483.15480.87220.06
Total Debt Issued
361551381.02483.15480.87220.06
Long-Term Debt Repaid
--472.81-387.19-434.1-268.19-157.47
Lease Payments
-11.49-11.49-8.89-8.68-6.73-2.76
Total Debt Repaid
-651.51-472.81-387.19-434.1-268.19-157.47
Net Debt Issued (Repaid)
-290.5178.19-6.1649.05212.6862.59
Issuance of Common Stock
-----49.27
Common Dividends Paid
-91.9-64.89-55.47-53.41-53.89-45.25
Other Financing Activities
1.06--1.49.162.43.95
Financing Cash Flow
-381.3513.3-63.034.79161.270.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.8-0.831.370.531.06-0.36
Net Cash Flow
-197.95176.6689.6557.7233.56-9.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
207.92186.07170.3447.17-124.91-247.16
Free Cash Flow Growth
41.54%9.23%261.09%---
Free Cash Flow Margin
14.87%13.94%13.14%4.08%-11.24%-23.71%
Free Cash Flow Per Share
1.541.371.260.35-0.93-1.85
Levered Free Cash Flow
196.3197.94122.94-23.51-90.86-214.39
Unlevered Free Cash Flow
203.2204.62131.58-13.98-83.05-209.99
Free Cash Flow After Leases
196.44174.58161.4538.49-131.65-249.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
68.8366.6670.0952.21-2.9925.21
Change in Working Capital
-58.58-58.58-49.56-78.01-66.84-165.09